Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement GlobeNewswire October 22, 2025 MELBOURNE, Australia and NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing innovative combination therapies for high-impact medical conditions, today announced that it has received an additional 180-calendar-day […]

Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 Virtual webinar to feature expert insights on unmet need, treatment landscape and potential clinical utility of Aryl Hydrocarbon Receptor (AhR) modulation in ulcerative colitis GlobeNewswire October 22, 2025 LA JOLLA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology

Axonius Advances Cybersecurity's Most Trusted Asset Intelligence Platform, Announcing New AI Automation and Exposure Management Capabilities GlobeNewswire October 22, 2025 New Axonius AI moves organizations from passive assessment to automated recommendations and response, closing the critical “actionability gap” New advancements in the Axonius Asset Cloud deliver deeper intelligence across all assets, from cloud instances to

SONORO GOLD ANNOUNCES CLOSING OF OVERSUBSCRIBED $4 MILLION PRIVATE PLACEMENT GlobeNewswire October 22, 2025 VANCOUVER, Canada, Oct. 22, 2025 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce that it has closed its previously announced oversubscribed, non-brokered private placement of 20,500,000 units

Synergy CHC (NASDAQ: SNYR) Deepens FOCUSfactor(R) Expansion with Kroger, PriceSmart & Wakefern — Strengthening U.S., Canada, and Global Reach GlobeNewswire October 22, 2025 WESTBROOK, Maine, Oct. 22, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced a series of major retail authorizations and distribution partnerships across

Alignment Health Plan Named a 2026 Best Insurance Company for Medicare Advantage Across All Its Markets by U.S. News & World Report Company earns “Best” ranking in Arizona, California, Nevada, North Carolina and Texas, reflecting strong performance in care quality, prevention and satisfaction GlobeNewswire October 22, 2025 ORANGE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) —

Madrigal Pharmaceuticals to Release Third-Quarter 2025 Financial Results and Host Webcast on November 4, 2025 GlobeNewswire October 22, 2025 CONSHOHOCKEN, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), announced today that it will release its third-quarter 2025 financial

New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning GlobeNewswire October 22, 2025 PLAN CALCIUM study to be presented at TCT 2025 conference highlights how AI-powered plaque analysis can inform lesion preparation and calcium modification planning NAVIGATE-PCI registry to enroll approximately 2,500 patients across approximately 30 sites to evaluate

Condor Provides an Operational Update on Its First Horizontal Well in Uzbekistan GlobeNewswire October 22, 2025 CALGARY, Alberta, Oct. 22, 2025 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company working in Central Asia is pleased to announce it has finished drilling the vertical portion

Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones Company to host shareholder webinar today, October 22, 2025, at 2:00 PM ET to review execution milestones, pipeline progress, and capital strategy GlobeNewswire October 22, 2025 WESTLAKE VILLAGE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Turn Therapeutics (Nasdaq: TTRX) (“Turn” or the